Pfizer and BioNTech climb after UK's MHRA grants authorization for emergency use for their COVID-19 mRNA vaccine Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Pfizer (PFE) and BioNTech (BNTX) up 3% and 4%, respectively, after announcing that the Medicines & Healthcare Products Regulatory Agency in the UK has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine BNT162b2 against COVID-19
- Tredegar (TG) up 29% after
declaring a special dividend of $200M, or $5.97 per share, on the company's common stock
- Asana (ASAN) up 1% after Piper Sandler analyst Brent Bracelin upgraded shares to Overweight from Neutral with a price target of $33
UP AFTER EARNINGS -
- NetApp (NTAP) up 8%
- TripAdvisor (TRIP) up 1%
DOWN AFTER EARNINGS -
LOWER -
- Salesforce (CRM) down 6% after earnings and confirming an agreement to acquire Slack (WORK) for $27.7B in cash and stock
- Moderna (MRNA) down 3% after Merck (MRK) announced that it divested its direct holding in Moderna in the first half of the fourth quarter
- Rexford Industrial (REXR) down 2% after 6M share spot secondary priced at $47.40
- iRhythm (IRTC) down 20% after commenting on the Centers for Medicare and Medicaid Services Calendar Year 2021 Medicare Physician Fee Schedule Final Rule that established payment policies, payment rates, and other provisions for services furnished under the MPFS on or after January 1, 2021
- FuelCell (FCEL) down 23% after 34.25M share spot secondary priced at $6.50
- Palantir (PLTR) down 13% after Morgan Stanley analyst Keith Weiss downgraded the stock to Underweight from Equal Weight with a $17 price target
- Slack Technologies (WORK) down 1% after entering a definitive agreement to be acquired by Salesforce
Symbols:
PFE MRNA - $141.06 /
-11.87 (-7.76%)
WORK PLTR FCEL IRTC REXR CRM TRIP NTAP TG ASAN BNTX MRK Keywords: Fly Intel, Wall Street, Top Stories, Stocks